BIOMAT Database Logo BIOMAT Database Logo

Hypoxanthine and inosine analogues as chemotherapeutic agents in Chagas' disease. 1988

J J Marr, and R L Berens
Department of Medicine, University of Colorado Health Sciences Center, Denver 80262.

Analogues of purines, especially those of hypoxanthine and inosine, appear to hold considerable promise for the treatment of Chagas' disease.

UI MeSH Term Description Entries
D007288 Inosine A purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in the anticodon of certain transfer RNA molecules. (Dorland, 28th ed)
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014344 Trypanocidal Agents Agents destructive to the protozoal organisms belonging to the suborder TRYPANOSOMATINA. Trypanocidal Drugs,Trypanocides,Trypanosomicidal Agents,Trypanosomicides,Agents, Trypanocidal,Agents, Trypanosomicidal,Drugs, Trypanocidal
D014355 Chagas Disease Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON. Trypanosomiasis, South American,American Trypanosomiasis,Chagas' Disease,Trypanosoma cruzi Infection,Infection, Trypanosoma cruzi,Infections, Trypanosoma cruzi,South American Trypanosomiasis,Trypanosoma cruzi Infections,Trypanosomiasis, American

Related Publications

J J Marr, and R L Berens
Oligonucleotide analogues as potential chemotherapeutic agents.
September 1988, Pharmaceutical research,
J J Marr, and R L Berens
Noscapine and analogues as potential chemotherapeutic agents.
November 2000, Drug news & perspectives,
J J Marr, and R L Berens
Phospholipid Analogues as Chemotherapeutic Agents Against Trypanosomatids.
January 2021, Current pharmaceutical design,
J J Marr, and R L Berens
Terminally alkylated polyamine analogues as chemotherapeutic agents.
January 2001, Journal of medicinal chemistry,
J J Marr, and R L Berens
Inosine, hypoxanthine, and seizures.
January 1983, Advances in neurology,
J J Marr, and R L Berens
Mycophenolic Acid and Its Derivatives as Potential Chemotherapeutic Agents Targeting Inosine Monophosphate Dehydrogenase in Trypanosoma congolense.
July 2016, Antimicrobial agents and chemotherapy,
J J Marr, and R L Berens
Inosine 5'-monophosphate vs inosine and hypoxanthine as substrates for purine salvage in human lymphoid cells.
September 1985, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
J J Marr, and R L Berens
Inosine 5'-monophosphate dehydrogenase as a chemotherapeutic target.
January 1994, Advances in experimental medicine and biology,
J J Marr, and R L Berens
De novo synthesis of hypoxanthine via inosine-5-phosphate and inosine.
June 1951, The Journal of biological chemistry,
J J Marr, and R L Berens
Hypoxanthine and inosine metabolism in cultured rat cardiomyocytes.
January 1991, Advances in experimental medicine and biology,
Copied contents to your clipboard!